NEW YORK (GenomeWeb News) — Shares in Solexa were up 29 percent and shares in Illumina were down 13 percent in midday trading after Illumina said this morning it plans to buy Solexa for roughly $600 million in stocks.
 
Solexa was trading up $2.83 a share at $12.51 while Illumina was trading down $5.75 at $38.28.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.